Short-term changes in serum luteinizing hormone, ovarian response and reproductive performance following gonadotrophin releasing hormone treatment in postpartum dairy cows with retained placenta.

Thirty-six postpartum Holstein cows consisting of eighteen cows that shed the placenta soon after calving (NRP) and eighteen cows that retained placenta greater than 24 h (RP) were used. There were four treatment groups. Group I consisted of 9 NRP cows which received intramuscular injection of sterile saline on day 15 postpartum. The second group consisted of 9 NRPN cows which received 100 micrograms of gonadotrophin releasing hormone on day 15 postpartum (NRPT). The third group consisted of 9 RP cows which received saline on day 15 postpartum (RPN) and the fourth group consisted of 9 RP cows which received 100 micrograms of gonadotrophin releasing hormone on day 15 postpartum (RPT). Blood samples were collected once daily during the first month and once every other day during the second month postpartum. In addition fourteen cows (RPT, n = 7; NRPT, n = 7), were used to study short-term changes in serum luteinizing hormone concentrations following gonadotrophin releasing hormone treatment on day 15 postpartum. Blood samples were obtained from these cows every 15 min during 1 h before and 6 h after gonadotrophin releasing hormone administration. Sera from all samples were assayed for progesterone and luteinizing hormone concentrations. Starting from four days after calving rectal palpations and ultrasound examinations of the ovaries were carried out once every four days until day 28 postpartum in order to monitor ovarian changes. All cows were inseminated on the first estrus after day 60 postpartum and examined for pregnancy between 35 and 42 days after insemination.(ABSTRACT TRUNCATED AT 250 WORDS)     

The effects of gonadotrophin releasing hormone administration in early postpartum dairy cows on hormone concentrations, ovarian activity and reproductive performance: a review

Gonadotrophin releasing hormones have become widely used hormonal compounds in veterinary medicine, particularly with respect to bovine reproduction. The character and physiological actions of gonadotrophin releasing hormone are briefly reviewed and its clinical applications are summarized. The endocrinological research concerned with the use of gonadotrophin releasing hormone in the early postpartum period is discussed. Field trials which have been conducted to assess the effects of postpartum gonadotrophin releasing hormone administration on reproductive performance have varied widely in both design and interpretation of results. These experiments are reviewed, including the clinical trials using normal cows as well as those on cows with retained placenta.     

Synchronisation of oestrus and reproductive performance of dairy cows following administration of oestradiol benzoate or gonadotrophin releasing hormone during a synchronised pro-oestrus

OBJECTIVE: To compare the use of gonadotrophin releasing hormone (GnRH) and oestradiol benzoate (ODB) administered following a synchronised pro-oestrus on reproductive performance of lactating dairy cows and the submission rates of non-pregnant cows following resynchronisation. DESIGN: Cohort study. PROCEDURE: Lactating Holstein cows enrolled in a controlled breeding program were first treated with an intravaginal progesterone releasing insert (IVP4) for 8 days, 2.0 mg of ODB intramuscular (i.m.) at device insertion (Day 0), an analogue of PGF2alpha at device removal and either 1.0 mg of ODB i.m., 24 h after device removal (ODB group, n = 242), or 0.25 mg of a GnRH agonist (GnRH group, n = 152) injected i.m. approximately 34 h after device removal. Every cow was artificially inseminated between 49 and 56 h after removal of its insert (Day 10). Cows detected in oestrus 1 day after artificial insemination (AI) that were not detected in oestrus on the previous day were re-inseminated on that day. All cows treated on Day 0 were resynchronised for reinsemination by insertion of a used IVP4 device on Day 23. Oestradiol benzoate at a dose of 1.0 mg was administered i.m. at the time of device insertion. Inserts were removed 8 days later (Day 31) and 1.0 mg of ODB was injected i.m. 24 h later. Those cows detected in oestrus between Days 31 and 35 were artificially inseminated. On Day 46 these cows were resynchronised for a third round of AI by insertion of an IVP4 device, used previously to synchronise cows for the first and second rounds of AI, and administration of 1.0 mg of ODB i.m.. Eight days later inserts were removed. Cows detected in oestrus between Days 54 and 58 were artificially inseminated. Bulls were run with the herd between rounds of AI and removed after 21 weeks of mating. RESULTS: Treatment with ODB or GnRH at the first synchronised pro-oestrus did not significantly alter the reproductive performance over three rounds of AI or over a 21-week breeding period. Treatment also did not alter submission rates at the second round of AI or the proportion of non-pregnant and non-return cows ('phantom' cows) detected and did not result in significant differences in concentrations of progesterone in plasma 10 and 18 days after removal of inserts at the first round of AI. Treatment with GnRH reduced the proportion of cows detected in oestrus at the first round of AI (36.2 vs 97.5%; P < 0.001). CONCLUSION: Administration of GnRH compared to ODB at a synchronised pro-oestrus results in similar reproductive performance. Treatment with GnRH reduced the proportion of cows detected in oestrus following treatment. This may offer advantages to the way AI is managed by enabling insemination at a fixed-time and removing the need for the detection of oestrus.     

Reproductive performance in dairy cows following postpartum treatment with gonadotrophin releasing hormone and/or prostaglandin: a field trial.

Three hundred and five Holstein Friesian cows were given either 250 micrograms gonadotrophin releasing hormone (GnRH) or saline on day 15 postpartum followed by 500 micrograms cloprostenol or saline on day 24 postpartum. Four treatment groups were formed using random allocation: Group I -- placebo (Day 15)/placebo (Day 24), Group II -- GnRH (Day 15)/placebo (Day 24), Group III -- placebo (Day 15)/cloprostenol (Day 24), Group IV -- GnRH (Day 15)/cloprostenol (Day 24). Double blind techniques were used during the follow-up period. Rectal palpation, to assess uterine involution and ovarian activity was performed just prior to each treatment and again at 28 days postpartum. In addition blood samples were collected at 15, 24 and 28 days postpartum for measurement of plasma progesterone. There were no significant differences among treatment groups with respect to services per conception, number of heats detected before first service and culling for infertility. Cows treated only with GnRH had an increased calving to first estrus and calving to first breeding interval, and tended to have an increased calving to conception interval. Treatment with cloprostenol significantly decreased calving to conception and calving to first observed estrus intervals. Treatment with GnRH on day 15 postpartum resulted in a significant increase in the subsequent incidence of pyometra and prebreeding anestrus. On the other hand, cloprostenol treatment on day 24 postpartum resulted in a decreased incidence of pyometra, regardless of GnRH treatment and a decreased incidence of prebreeding anestrus in GnRH treated cows compared to cows receiving only GnRH at day 15 postpartum.(ABSTRACT TRUNCATED AT 250 WORDS)     

Effects of prostaglandin on the reproductive performance of dairy cows

A single injection of a synthetic analogue of prostaglandin F2 alpha (fenprostalene; Syntex) on the day of calving or between days 14 and 21 after calving did not affect the calving to first service interval, the number of services per conception or the conception rate of dairy cows. In a second trial, cows calved more than 45 days were injected once weekly with prostaglandin F2 alpha (dinoprost; Upjohn) or fenprostalene until served at the first detected oestrus. The calving to first service interval and the conception rate were not affected. Following injection of either prostaglandin, the spread in the pattern of onset of oestrus and the range in the proportion of cows (75 to 98 per cent) seen in oestrus within seven days were similar. This variation in the time of onset of oestrus after the administration of prostaglandin precludes limiting oestrus detection to four or five days per week, and is a major limitation to the use of prostaglandins in breeding programmes in dairy cows.     

Gonadotropin-releasing hormone improves reproductive performance of dairy cows with slow involution of the reproductive tract

Eighty multiparous Holstein cows were assigned randomly at calving to receive either 100 microg of GnRH or saline 13 or 14 d postpartum (PP). From 4 to 28 d PP the cows' reproductive organs were palpated weekly per rectum, and cows were subclassified within each group as undergoing slow (delayed) cervical and uterine involution (abnormal) or as normal cows. Last milk obtained after removing the milking machine was assayed for progesterone 3 times a week for 120 d PP. Fourteen of the 80 cows were removed from the experiment because of culling or various veterinary treatments of pathologic conditions that could confound analysis of the GnRH treatment effects. As expected, the treatment of normal cows with GnRH had no significant effects on the first estrus or the first estrous cycle PP, on services per conception, days open, or any other reproductive trait measured. However, in the abnormal group of cows receiving saline, first rebreeding after calving was delayed (81 vs. 67 d), fewer were pregnant by 105 d PP (23 vs. 64%), and number of days open was greater (121 vs. 87 d) compared with those receiving GnRH; all were significant (P<.05). Treated abnormal cows were equivalent to the control normal cows. Thus, GnRH given 13 to 14 d PP to cows characterized as undergoing slow involution of the reproductive system, but with no other clinical problems, seems to assist in promoting rapid normal reproductive function. Subsequent losses due to culling were greatly reduced.     

Economic and reproductive consequences of retained placenta in dairy cattle

The financial losses due to retained placenta in Dutch dairy cattle were estimated by using two different methods of calculation. A data-set containing the birth records of 160,188 Meuse-Rhine-Yssel cows provided data on the reproductive performance of cows with and without retained placenta. The fertility of cows after retention of the placenta appeared to be affected. An economic calculation made by adding the losses due to increased calving interval, increased culling rate, loss of milk production and the costs of veterinary treatment and drugs revealed that the total loss due to retained placenta was 471 pounds per year for a 100-cow farm with an average incidence of the condition (6.6 per cent). For a 'problem' farm with a 30 per cent rate, the loss was 2139 pounds per year. A computer farm simulation model, based on a stochastic determination of events, was used to make calculations for circumstances closely resembling those on farms. A 6.6 per cent rate of retained placenta caused a small but significant decrease in net return on labour and management; however, a 30 per cent rate caused highly significant changes. The economic effects of retained placenta were similar in magnitude in herds of high or low productivity and high or low fertility. Sensitivity analysis showed that the greatest financial losses were caused by loss of milk production, followed by the number of animals suffering from complications. The financial losses in herds with an average rate of retained placenta were thus of limited economic importance and therapeutic measures alone should be adequate.(ABSTRACT TRUNCATED AT 250 WORDS)     

The effects of gonadotrophin releasing hormone administration four days after insemination on first-service conception rates and corpus luteum function in dairy cows.

One hundred and eighty-five Holstein-Friesian dairy cows received either sterile water or 250 micrograms of gonadotrophin releasing hormone intramuscularly on the fourth day after the first service postpartum. Heparinized blood samples were taken immediately prior to treatment (day 4) and on day 8 postinsemination for analysis of plasma progesterone concentration. Pregnancy diagnosis was carried out by rectal palpation at 42 days postinsemination and reconfirmed after 60 days postbreeding. The pregnancy rates after first, second or third service were not significantly different between gonadotrophin releasing hormone-treated and control cows. Plasma progesterone concentrations on day 4 and day 8 postinsemination, as well as the change in plasma progesterone concentration from day 4 to day 8, were similar for gonadotrophin releasing hormone-treated and control cows. The plasma progesterone concentrations on day 8 postbreeding were significantly higher (p less than 0.005) and the change in progesterone concentrations between days 4 and 8 were significantly greater (p less than 0.002) in pregnant cows compared to nonpregnant cows.     

Culling of dairy cows. Part II. Effects of diseases and reproductive performance on culling in Finnish Ayrshire cows

The effects of 15 diseases and reproductive performance on culling were studied in 39 727 Finnish Ayrshire cows that calved in 1993 and were followed until culling or next calving. Survival analysis, using the Cox proportional hazards model, was performed with diseases and pregnancy status as time-dependent covariates. Parity, calving season and herd were included as covariates in every model. The effect of the number of inseminations was also studied.

The farmer's knowledge of the cow's pregnancy status had a significant effect on culling. It varied according to the stage of lactation a cow was in; the earlier the farmer knew a cow was pregnant, the smaller was the risk of culling. If a cow had not been inseminated at all, her risk of culling was 10 times higher than if she was inseminated once. If a cow was inseminated more than once, she had a slightly lower risk of being culled than a cow inseminated only once. The effect of parity decreased when pregnancy status and number of inseminations were added to the model, indicating that part of the parity effect was accounted for by reproductive performance. Including diseases in the model with pregnancy status and the number of inseminations did not change the effects of reproductive performance on culling.

Mastitis, teat injuries and lameness had the greatest effect on culling (whether adjusted for reproductive performance or not), increasing the risk of culling, followed by anestrus, ovarian cysts and milk fever. In general, the effects of diseases decreased when reproductive performance was also accounted for in the model. When pregnancy status was included in the model, the effects of anestrus and ovarian cysts became slightly more protective, but when the number of inseminations was also considered, they became non-significant at the beginning of lactation and they increased the risk of culling at the end of lactation.

Sensitivity analysis, which was run to evaluate the effects of our censoring mechanism on the results, indicated that the censoring times (i.e., the time of next calving) were not fully independent of the event (culling) times; the effects of the diseases and pregnancy status at the very end of the lactation changed slightly from the original model.     

Effect of feeding on reproductive performance in Finnish dairy cows

The effect of 2 types of feeding on the involution of the genital tract and on the fertility was studied in 79 Finnish dairy cows on a research farm. The cows were fed twice a day with home-produced feed in accordance with the Finnish feeding standard. The cows were divided according to the type of feed into a hay-urea group and a silage group. The cows were examined clinically by rectal palpation 3 times a week during 8 weeks postpartum. The time required for the complete involution of uterus and cervix was recorded. The cows in the silage group had a significantly longer time in uterine involution, a lower fertility rate at first insemination and a longer interval from calving to conception than those in the hay-urea group. The pregnancy rate in the first insemination was in the hay-urea group 91% and in the silage group 57%. The interval between calving and the first insemination was shorter in the hay-urea group than in the silage group: 71.4 +/- 10.6 and 74.0 +/- 10.3 days, respectively. The interval between calving and conception was in the hay-urea group significantly (p less than 0.01) shorter than in the silage group; 74.8 +/- 15.1 and 89.5 +/- 24.4 days, respectively.     

A hospital-based study of the relationship between retained placenta and mastitis in dairy cows

We investigated the relation between retained placenta and mastitis in Holstein dairy cows admitted to the New York State College of Veterinary Medicine. Cows with retained placenta were three times more likely to develop mastitis during hospitalization than animals without retained placenta. Since the hospital population was not representative of the general population, the possibility of a bias existed; a large bias was not likely because most distorting variables occurred equally in animals both with and without retained placenta. The literature suggests that the relationship between retained placenta and mastitis may be mediated through activity of the peripheral leukocytes. Further research is necessary to test this hypothesis.     

Effects of periparturient diseases and conditions on the reproductive performance of New Zealand dairy cows

AIM: To determine the effect of retained foetal membranes (RFM), periparturient recumbency, calf mortality, dystocia, twin births and induction of parturition on submission and pregnancy rates of pasture-fed, seasonally-calving dairy cows in New Zealand. METHODS: Data were retrospectively collected for 2652 cows from 11 herds on the occurrence of periparturient diseases and condition, calving date, age and treatment for anoestrus prior to the planned start of mating (PSM). The effects of each disease or condition on submission and pregnancy rate by 28 days after PSM, final pregnancy rate, and the proportion of cows that conceived more than 50 days after PSM were examined using separate logistic regression models. Results are expressed as odds ratios (OR). Additionally, the effect of each disease or condition on the interval from PSM to conception was examined using survival analysis. Age, herd and late calving (i.e. cows calved < or =40 days before PSM) were included as factors in the models examined. RESULTS: Induction of parturition increased the risk of RFM (OR=3.3, p<0.01). The 28-day submission rate was affected by age and herd but not by any of the periparturient conditions examined. The 28-day pregnancy rate was reduced by RFM (OR=0.04, p<0.05), induction of parturition (OR=0.67, p<0.01), assisted calving (OR=0.61, p<0.01), late calving (OR=0.55, p<0.05) and anoestrus (OR=0.27, p<0.05). The final pregnancy rate was reduced by RFM (OR=0.013, p<0.01), induction (OR=0.25, p<0.05), assisted calving (OR=0.30, p<0.005) and anoestrus (OR=0.32, p<0.05), and was increased if the cow was submitted for mating within 28 days after PSM (OR=2.72, p<0.05). Effects of recumbency and twinning were not significant in any of the models. CONCLUSIONS: Cows that had had RFM or were assisted, induced or late to calve, had significantly lower pregnancy rates or took longer to conceive than unaffected herd-mates. CLINICAL RELEVANCE: Intervention programs aimed at the examination and treatment of cows with periparturient conditions may improve the reproductive performance of New Zealand dairy herds. Investigations of poor reproductive performance of a herd should include analysis of the prevalence and effects of periparturient diseases and conditions.     

Effects of growth hormone and gonadotrophin releasing hormone antagonists on ovarian follicle growth in sheep

Our objective was to determine the effects of the administration of growth hormone (GH) alone or plus teverelix, a gonadotrophin releasing hormone antagonist (GnRHa), on follicle development in sheep. Ewes were treated daily for 6 days by the intramuscular route with 15 mg of GH alone (GH group; n = 6) or combined with two subcutaneous doses of GnRHa (1.5 mg) on days 0 and 3 of GH treatment (GH/GnRHa group; n = 6); the control group (n = 6) received similar treatment with saline solution. Plasma follicle stimulating hormone levels were significantly lower in the GH/GnRHa group than in the control (P < 0.001) and GH groups (P < 0.05). The number of follicles > or =2 mm increased to reach significant differences with control (18.7 +/- 0.6) on day 4 in GH/GnRHa group (22.7 +/- 0.5, P < 0.001) and on day 5 in GH group (20.3 +/- 0.4 vs. 17.0 +/- 0.6, P < 0.05). These results indicate that GH and GnRHa may be useful for increasing the number of gonadotrophin-responsive follicles in the ovary. However, follicle function could be affected as both GH and GH/GnRHa groups showed lower plasma inhibin A concentrations than control sheep (90-110 pg/mL vs. 170-185 pg/mL, P < 0.005).     

Strategy for the treatment of puerperal metritis and improvement of reproductive efficiency in cows with retained placenta

The objective of this study was to improve the reproductive efficiency of dairy cows with puerperal metritis (PM) subsequent to retained placenta (RP) using a two-step treatment strategy. A total of 188 postpartum cows, aged from 2 to 8 years, were utilised for 2 experiments. In Experiment 1, cows affected with RP/PM were randomly assigned to two treatment groups. Cows in Group A (n = 17) were treated with 600 mg of ceftiofur intramuscularly for 3 days followed by intrauterine lavage with 0.1% chlorhexidine and infusion with 0.5% povidoneiodine, while cows in Group B (n = 16) received two intrauterine infusions, first with 5 g of oxytetracycline and then with 0.5% povidone-iodine. Cows with normal postpartum findings were regarded as the healthy control group (n = 26). Ultrasonographic examination revealed that the ovarian activities including the appearance of a dominant follicle and days to first ovulation of the cows in Group A during the early postpartum period differed from those of Group B (P < 0.05), which coincided with the results of uterine swabbing for bacteriology. In Experiment 2, cows with normal postpartum findings were allocated to Group D (n = 78), which received an ovulation protocol (GnRH - 7 d PGF2α - 48 h hCG - 24 h AI) on day 50 ± 2 postpartum. Cows affected with PM were randomly divided into two groups, Group E (n = 25) combined the treatments applied in Groups A and D, while Group F (n = 26) repeated the treatment administered in Group E except for uterine lavage. The results indicated that the pregnancy rate within 150 days postpartum and the mean days open in Group E (76.0% and 106.3 ± 4.6 days, respectively) were significantly different from those in Group F (38.5% and 137.9 ± 10.9 days, respectively) (P < 0.05). This study suggests that reproductive efficiency could be improved by using the two-step treatment to regulate uterine involution and an early resumption of ovarian function in cows with RP/PM.     

The relationship between mastitis and retained placenta in a commercial population of holstein dairy cows

The relationship between retained placenta and mastitis was studied in a population of dairy cows on commercial farms. Only mastitis cases which occurred shortly after calving were studied. The cows with retained placenta were at a higher risk of developing non-severe mastitis (relative risk = 1.5) and at a much higher risk of developing severe mastitis (relative risk = 5.4). There was a differential effect of long-term (> 6 days) versus short-term (< 5 days) retained placenta.It is suggested that the relationship between retained placenta and mastitis is moderated by the prepartum peripheral leukocyte activity.     

Effects of work on reproductive and productive performance of crossbred dairy cows in the Ethiopian highlands

Summary An investigation was made at the International Livestock Centre for Africa (ILCA), into the possibility of using cows in land cultivation as a means of reducing the dependency of smallholder farmers in the Ethiopian highlands on draught oxen power, a resource which is in short supply during the peak of the cultivation season and usually leads to late planting and poor harvest. A total of 32 crossbred cows (1/2 Boran −1/2 Friesian) were used in an experiment to determine whether cows could be used to cultivate an average smallholder farm of 2·5 ha and to assess the effects of work on reproductive and productive performance; 16 served as a control group and were milked, but not worked while the other 16 were milked in addition to providing draught power for cultivation. Draught cows were provided with extra feed and consumed 7% and 21% more hay and concentrate respectively than non-draught cows during a two-lactation cycle. After the end of the second lactation there were no significant differences between draught and non-draught animals for milk production (1,713±57·4 compared with [vs] 1,857±48·1 kg), lactation length (291±20·4 vs 277±18·0 days), calf birth weight (29·6±1·0 vs 29·3±1·0 kg), number of days open (77±14·1 vs 83±12·9), calving interval (355±14·5 vs 358±13·2 days), gestation length (278±1·6 vs 274±1·4 days) and number of services per conception (1·21 vs 1·64). The number of hours worked by each pair of crossbred cows was sufficient to cultivate the average smallholder farm of 2·5 ha. However, the work done was spread over a longer time than that required by the smallholder farmer to cultivate 2·5 ha. It was concluded that at low levels of work and with improved feeding management, draught or traction does not have adverse effects on reproductive and productive performance of crossbred dairy cows.

---

Resumen Se realizó una investigación en el Centro Internacional de Ganadería para Africa (ILCA), sobre el uso de vacas en el cultivo de la tierra en lugar de bueyes, los cuales son escasos en la época pico de labranza, lo cual conlleva a que se siembre tarde con la consecuente baja producción. Se utilizaron para el estudio 32 vacas media sangre Borán/Holstein, para determinar si éstas podían servir para las labores de cultivo de peque?as fincas de 2·5 hectáreas, sin menoscabo de la producción y reproducción. Dieciseis sirvieron como controles, las que se orde?aron pero no se utilizaron en labores de cultivo. Las vacas que se utilizaron para trabajar, recibieron alimentación extra, consumiendo 7% y 21% más heno y concentrado, durante dos ciclos de lactación.

---

Résumé Une enquête a été réalisée à l'ILCA/CIPEA sur la possibilité d'utiliser des vaches pour cultiver la terre, en vue de réduire, la dépendance des petits fermiers des Hautes Terres éthiopiennes vis à vis des disponibilités en boeufs de trait. Cette ressource est en effet limitée pendant la pointe de la saison des cultures, et ceci a pour conséquences des plantations tardives et une moisson médiocre. Un total de 32 vaches croisées (1/2 Boran −1/2 Frison) ont été utilisées pour essayer de déterminer si ces animaux pouvaient être employés pour les travaux de cultures sur une ferme moyenne de 2,5 ha de superficie représentative d'une petite propriété et pour mesurer les effects du travail sur les performances de production laitière et de reproduction. Seize ont constitué un lot témoin. Elles ont été traites mais, n'ont pas travaillé tandis que 16 autres ont été traites tout en apportant leur force de travail pour la culture. Les vaches de trait ont re?u une alimentation complémentaire et ont respectivement consommé 7% et 21% de foin et de concentré de plus que les vaches non utilisées pour la traction pendant un cycle de 2 lactations.

     

Rationale for treatment of retained placenta in cows with neomycin and metronidazole.

A combination of neomycin and metronidazole was compared with oxytetracycline for its activity against the intrauterine flora of 10 cows with retained placenta. In vitro the metronidazole/neomycin combination reduced the numbers of aerobic and obligately anaerobic bacteria much more effectively than did oxytetracycline.